Page 3 - Ryan Weispfenning News Today

DUBLIN, Dec. 18, 2023 /CNW/ -- Medtronic plc , a global leader in healthcare technology, today announced it will participate in the 42nd annual J.P. Morgan healthcare conference on Monday, January 8,...

/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 42nd annual J.P. Morgan...

Safe, efficient, and effective treatment for both paroxysmal and persistent atrial fibrillation DUBLIN, Dec. 13, 2023 /PRNewswire/ -- Medtronic plc , a global leader in healthcare technology, today...

/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the United States Food and Drug Administration (FDA)...

DUBLIN, Dec. 7, 2023 /PRNewswire/ -- The board of directors of Medtronic plc on Thursday, December 7, 2023, approved the companys cash dividend for the third quarter of fiscal year 2024 of...

/PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, December 7, 2023, approved the companys cash dividend for the third quarter of...

Medtronic plc (NYSE:MDT) Q4 2024 Earnings Call Transcript November 21, 2023 Medtronic plc beats earnings expectations. Reported EPS is $1.25, expectations were $1.18. Ryan Weispfenning: Good morning. Welcome to a crisp fall morning here in Minnesota. I’m Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations. And I appreciate that you’re joining us this […]

/PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2024 (FY24), which ended October 27, 2023. Key...

MDT earnings call for the period ending September 30, 2023.

The Symplicity™ blood pressure procedure offers patients a new adjunct approach to lowering blood pressure Approval is the culmination of ten years of clinical research and development of the...